A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)
Status:
NOT_YET_RECRUITING
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
This is a A multicenter, open label, phase II clinical study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics(PD), and preliminary efficacy of AK120 in adolescents with moderate-to-severe atopic dermatitis